cystic-fibrosis

Documents about cystic-fibrosis

• Combating Diagnostic Wandering and Impasse for Cystic Fibrosis#803082ClinicalTrials.gov
• A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF)#806215ClinicalTrials.gov
• Video Telehealth Exercise Training in Cystic Fibrosis#807912ClinicalTrials.gov
• Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis#832885ClinicalTrials.gov
• COVID-19 Antibody Responses in Cystic Fibrosis#836149ClinicalTrials.gov
• Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)#853313ClinicalTrials.gov
• Airway Microbiome of Cystic Fibrosis Patients#872030ClinicalTrials.gov
• Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis#872725ClinicalTrials.gov
• Intravenous Iron in Adults With Cystic Fibrosis#874445ClinicalTrials.gov
• Zoledronic Acid in Cystic Fibrosis#897130ClinicalTrials.gov
• Continuous Cardiorespiratory Monitoring in Cystic Fibrosis#906964ClinicalTrials.gov
• Home Monitoring to Predict Exacerbation in Cystic Fibrosis#912075ClinicalTrials.gov
• The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis#230334ClinicalTrials.gov
• Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients#829567ClinicalTrials.gov
• Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis#841730ClinicalTrials.gov
• Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit#872813ClinicalTrials.gov
• Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis#143586ClinicalTrials.gov
• Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations#146204ClinicalTrials.gov
• Microbial Biomarkers of EArly Pseudomonas Aeruginosa Colonization in CHildren With Cystic Fibrosis#226303ClinicalTrials.gov
• Redox Imbalance and the Development of Cystic Fibrosis Diabetes#238261ClinicalTrials.gov
• Steps Ahead: Optimising Physical Activity and Health in Adults With Cystic Fibrosis#325239ClinicalTrials.gov
• Closed-loop for People Living With Cystic Fibrosis Related Diabetes#432839ClinicalTrials.gov
• Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)#481777ClinicalTrials.gov
• Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis#825258ClinicalTrials.gov
• Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis#834372ClinicalTrials.gov
• Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.#861143ClinicalTrials.gov
• FDG-PET Imaging in Young Cystic Fibrosis Patients#866381ClinicalTrials.gov
• Electrical Impedance Imaging of Patients With Cystic Fibrosis#869670ClinicalTrials.gov
• Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis#871824ClinicalTrials.gov
• Costs of Care and Adherence to Treatment for Cystic Fibrosis#893069ClinicalTrials.gov
• Fidgety Movements in Cystic Fibrosis#916600ClinicalTrials.gov
• Pre-emptive Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Cystic Fibrosis Related Liver Disease#141122ClinicalTrials.gov
• The Use of Home Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes#257047ClinicalTrials.gov
• Evaluation of a Decision Aid for Adult Cystic Fibrosis Patients Considering Bilateral Lung Transplantation#813370ClinicalTrials.gov
• Nutritional Status Assessment of Pediatric Cystic Fibrosis Patients and Effect of Nutrition Education on Nutritional Status#855488ClinicalTrials.gov
• A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis#870633ClinicalTrials.gov
• Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis#872362ClinicalTrials.gov
• Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis#28372ClinicalTrials.gov
• Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.#321628ClinicalTrials.gov
• Measurement of Beta Cell Death in Individuals With Cystic Fibrosis#803677ClinicalTrials.gov
• Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study#807715ClinicalTrials.gov
• A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis#843456ClinicalTrials.gov
• Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis#853358ClinicalTrials.gov
• Study of Individualized Physiotherapy for Airway Clearance in Cystic Fibrosis.#855008ClinicalTrials.gov
• Glucose Tolerance in Children With Cystic Fibrosis#866304ClinicalTrials.gov
• Cystic Fibrosis - Insulin Deficiency, Early Action#887325ClinicalTrials.gov
• In Vitro Model of the Cystic Fibrosis Bronchial Epithelium Via iPS Technology#893156ClinicalTrials.gov
• RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum#897234ClinicalTrials.gov
• Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients#979977ClinicalTrials.gov
• Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients#904908ClinicalTrials.gov